Further, the value of KL-6 as a biomarker for ILD extends to diverse ethnic populations throughout the world, despite the fact that polymorphisms in the MUC1 gene affect serum levels of KL-6 (177–179). The gene discussed is MUC1; the disease is interstitial lung disease.